Literature DB >> 1635924

Immunological and antitumor effects of coumarin and some derivatives.

F Rosskopf1, J Kraus, G Franz.   

Abstract

Coumarin and its 4-OH and 7-OH derivatives, as well as o-, m- and p-coumaric acid were tested against P-815 and P-388 tumor cells in vitro. In addition, the compounds were investigated in various in vitro immunological test systems and genuine coumarin was tested furthermore against the Sarcoma-180 in CD1 mice. In vivo, coumarin showed only a moderate antitumor effect against the allogeneic Sarcoma-180 at concentrations of 10 and 40 mg/kg, with inhibition rates of 49 and 60%, respectively. However, both concentrations were markedly toxic. In vitro all compounds were more or less cytotoxic against P-815 and P-388 tumor cell lines starting at a concentration of 100 micrograms/ml. At subtoxic concentrations (less than or equal to 10 micrograms/ml) the samples showed no mitogenic activity against murine spleen lymphocytes and PHA costimulated human peripheral blood lymphocytes. Furthermore, with the coumarin derivatives neither cytotoxic macrophages could be induced against P-815 tumor cells nor an increased release of Il-2 and TNF-alpha could be observed. Only 7-OH coumarin, in concentrations of 2 and 20 micrograms/ml, caused a strong increase in phagocytosis of 124 and 84% in both, human peripheral blood granulocytes and murine peritoneal macrophages, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1635924

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  9 in total

1.  5-O-β-D-galactopyranosyl-7-methoxy-3',4'-dihydroxy-4-phenylcoumarin, an inhibitor of photophosphorylation in spinach chloroplasts.

Authors:  M R Calera; R Mata; A L Anaya; B Lotina-Hennsen
Journal:  Photosynth Res       Date:  1995-08       Impact factor: 3.573

2.  Mode of action of coumarin in immune cells.

Authors:  G J Zlabinger; C Nöhammer; G A Böhmig; J E Menzel
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Antitumour activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinomas.

Authors:  A Maucher; E von Angerer
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Evaluation of the antitumour activity of coumarin in prostate cancer models.

Authors:  A Maucher; M Kager; E von Angerer
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  The structure-activity relationship between oxycoumarin derivatives showing inhibitory effects on iNOS in mouse macrophage RAW264.7 cells.

Authors:  Tomonori Nakamura; Naoko Kodama; Manabu Oda; Shizuko Tsuchiya; Yu Arai; Takuya Kumamoto; Tsutomu Ishikawa; Koichi Ueno; Shingo Yano
Journal:  J Nat Med       Date:  2008-07-09       Impact factor: 2.343

6.  Antihuman Immunodeficiency Virus Type 1 (HIV-1) Activity of Rare Earth Metal Complexes of 4-Hydroxycoumarins in Cell Culture.

Authors:  Ilia Manolov; Sevda Raleva; Petya Genova; Alexey Savov; Liliana Froloshka; Daniela Dundarova; Radka Argirova
Journal:  Bioinorg Chem Appl       Date:  2006-03-02       Impact factor: 7.778

7.  Farnesiferol C induces cell cycle arrest and apoptosis mediated by oxidative stress in MCF-7 cell line.

Authors:  Davoud Hasanzadeh; Majid Mahdavi; Gholamreza Dehghan; Hojjatollah Nozad Charoudeh
Journal:  Toxicol Rep       Date:  2017-08-01

Review 8.  Saposhnikovia divaricata-An Ethnopharmacological, Phytochemical and Pharmacological Review.

Authors:  Min Yang; Cong-Cong Wang; Wen-le Wang; Jian-Ping Xu; Jie Wang; Chun-Hong Zhang; Min-Hui Li
Journal:  Chin J Integr Med       Date:  2020-04-21       Impact factor: 1.978

9.  Novel coumarin-benzimidazole derivatives as antioxidants and safer anti-inflammatory agents.

Authors:  Radha Krishan Arora; Navneet Kaur; Yogita Bansal; Gulshan Bansal
Journal:  Acta Pharm Sin B       Date:  2014-08-10       Impact factor: 11.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.